Moderna: easily beat profit and revenue forecasts. For investors, the past year seemed to be an open-book test. Crushed ...
Moderna reported a profit of $8.58 a share, easily topping analyst estimates for a profit of $5.37, on revenue of $6 billion, trouncing forecasts for $4.204 billion.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.